Skip to main content
Figure 3 | Cancer Cell International

Figure 3

From: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

Figure 3

Effect of Adriamycin/Anti-SCF on Bcl-2 Expression in MCF-7/AdrRes Cells. Cell lysates were used to determine the expression of Bcl-2 using ELISA after treatment with the drug adriamycin (D) + SCF, D + anti-SCF, D + SCF + anti-SCF and Drug alone. For each individual experiment data are represented as the mean ± SE of duplicate determinations of 1.25 × 104 cells. ANOVA showed a significant* difference (p < 0.05) between treatments (D) ± SCF and D ± anti-SCF, D ± SCF ± anti-SCF and Drug alone.

Back to article page